PODE 2006 Population Optimum Design of Experiments: Workshop |
|
10.00 - 10.30 |
Tea/Coffee (room 102) |
Morning Session 10.30 - 11.00 11.00 - 11.30 11.30 - 12.00 12.00 - 12.30 |
(room 103) Sylvie Retout, Emmanuelle Comets, Adeline
Samson and France Mentre Designs in Nonlinear Mixed Effects Models:
Evaluation and Optimisation of the Power of the Wald Test With Application to
HIV Viral Load Decrease (abstract, slides) Kay Ogungbenro and Leon Aarons A General Method for Optimal Design of Univariate
and Multivariate Population Pharmacokinetic Experiments (abstract,
slides) Rainer Schwabe and Thomas Schmelter On Optimal Designs in Random Coefficient Regression
Models and Alike (abstract, slides) Maciej Patan and Basia Bogacka Generalized Definition of the Statistical
Population Design (abstract, slides) |
12.30 - 14.00 |
Lunch (The Gallery) |
Afternoon Session 14.00 - 14.25 14.25 - 14.50 14.50 - 15.15 15.15 - 15.40 |
(room 103) Valerii Fedorov and Sergei Leonov Estimation of Sophie Glatt, Kayode Ogungbenro and Ivelina Gueorguieva Optimal Design for First In Human Studies to
Investigate the Pharmacokinetic/Pharmacodynamic Behaviour of TGF-Beta RI
Kinase Inhibitor (abstract, slides) Aris Dokoumetzidis and Leon Aarons Numerical Investigation of the Number of Design
Points in Bayesian D-Optimal Designs in Respect to Prior Uncertainty (abstract, slides) Paddy Johnson, Gordon Graham and Byron Jones SWOT Analysis of Optimal Design in the
Pharmaceutical Industry - Pfizer Perspective (abstract,
slides) |
15.40 - 16.10 |
Tea/Coffee (room 102) |
16.10 - 17.00 |
DISCUSSION (room G2) |
~ PODE ~ |